Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed with results

Key Signals

5 with results88% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (8)
Early P 1 (1)
P 2 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed7
Recruiting2
Unknown2
Terminated1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07450495Not ApplicableRecruitingPrimary

Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery

NCT07405138Not ApplicableNot Yet RecruitingPrimary

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

NCT07039461Not ApplicableTerminatedPrimary

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

NCT05512572Not ApplicableUnknownPrimary

Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion

NCT05070611Not ApplicableUnknownPrimary

Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia

NCT03248440Phase 3CompletedPrimary

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

NCT04322500Not ApplicableCompletedPrimary

Probiotics for Chalaziosis Treatment in Children

NCT04342507Not ApplicableCompletedPrimary

Probiotics for Treatment of Chalazion in Adults

NCT02025023Phase 3RecruitingPrimary

Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

NCT02338648Phase 2CompletedPrimary

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

NCT01763437Early Phase 1Withdrawn

Intralesional Tetracycline Injection in the Treatment of Chalazia

NCT00832130Not ApplicableCompletedPrimary

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

NCT01202747Phase 2CompletedPrimary

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

NCT00420628Phase 4CompletedPrimary

Pediatric Zylet Safety and Efficacy Study

Showing all 14 trials

Research Network

Activity Timeline